← Leaderboards
Lawren Vandevrede
University Of California, San Francisco
$1,005,750
Attributed
$1,005,750
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $201.2K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,005,750 · 1
By mechanism
K23$1,005,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Adam Mark Staffaroni$4,706,290
- Chloe E. Atreya$2,763,065
- Martin Kampmann$17,201,095
- Jean-Philippe Francois Marie Coppe$2,137,183
- Andrew Chris Yang$6,850,857
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAlzheimerâS Disease BiomarkerBloodAlzheimer Disease ScreeningAmyloid Beta-42Amyloid Beta-ProteinArea Under CurveAutopsyAmyloidBehavioralBenchmarkingBiological MarkersBiomarker DiscoveryBiomarker ValidationClinical DiagnosisBlood TestsCaliforniaCareerCareer DevelopmentCerebrospinal FluidClinicClinical ApplicationClinical Dementia Rating ScaleClinically Relevant
Grant awards (5)
Validation of Novel Plasma Biomarkers for Mixed Etiology Dementia$201,150
K23 · FY2025 · AG · contact PI
Validation of Novel Plasma Biomarkers for Mixed Etiology Dementia$201,150
K23 · FY2024 · AG · contact PI
Validation of Novel Plasma Biomarkers for Mixed Etiology Dementia$201,150
K23 · FY2023 · AG · contact PI
Validation of Novel Plasma Biomarkers for Mixed Etiology Dementia$201,150
K23 · FY2022 · AG · contact PI
Validation of Novel Plasma Biomarkers for Mixed Etiology Dementia$201,150
K23 · FY2021 · AG · contact PI